T1 Biomarker 396 398 ER
T2 Condition 395 399  ER 
T3 Protein 666 669 AKT
T4 Biomarker 635 637 ER
T5 Biomarker 990 992 ER
T6 Condition 492 496  ER 
T7 Condition 990 1015 ER-positive breast cancer
T8 Protein 160 165 PI3Kα
T9 Gene 36 40 gene
T10 Protein 24 30 PIK3CA
T11 Gene 971 975 gene
T12 Condition 145 158 breast cancer
T13 Intervention 545 552 samples
T14 Protein 554 559 KMT2D
T15 Protein 436 441 PI3Kα
T16 Protein 81 86 PI3Kα
T17 Intervention 470 479 chromatin
T18 Gene 493 507 ER target loci
T19 Condition 511 524 breast cancer
T20 Condition 11 20 mutations
T22 Biomarker 493 495 ER
T23 Protein 766 771 PI3Kα
T24 Condition 744 748  ER 
T25 Condition 113 131 estrogen receptor 
T26 Protein 792 797 KMT2D
T27 Biomarker 132 134 ER
T28 Protein 695 700 KMT2D
T29 Biomarker 259 271 ER-dependent
T30 Biomarker 875 877 ER
T31 Protein 563 600 histone H3 lysine 4 methyltransferase
T32 Gene_or_gene_product 160 176 PI3Kα inhibitors
T33 Intervention 340 349 chromatin
T34 Biomarker 745 747 ER
T35 Condition 634 638  ER 
T36 Protein 625 629 PBX1
T37 Protein 404 409 PI3Kα
T38 Biomarker 259 261 ER
T39 Gene 922 926 gene
T40 Protein 618 623 FOXA1
T41 Condition 874 878  ER 
R1 Relation Arg1:T29 Arg2:T38
